Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

APOBEC3H Inhibitors

The chemical class referred to as APOBEC3H inhibitors encompasses a specialized group of organic compounds designed to selectively modulate the enzymatic activity of the APOBEC3H enzyme. APOBEC3H is a member of the APOBEC3 family of cytidine deaminases, known for their critical roles in the innate immune defense against retroviruses and retrotransposons by inducing genetic mutations in their genetic material. Inhibitors within this class are meticulously engineered to interact with specific binding sites on the APOBEC3H enzyme, thereby disrupting its catalytic function. By doing so, these inhibitors have the ability to affect the hypermutation activity of APOBEC3H, influencing its role in restricting the replication of retroviruses and contributing to the host's innate immunity. The development of APOBEC3H inhibitors often involves a combination of advanced molecular modeling, structure-activity relationship studies, and bioinformatics analysis. These approaches aim to optimize the inhibitors for heightened specificity toward APOBEC3H, increased potency, and improved compatibility with the cellular environment. A deep understanding of the structural intricacies of APOBEC3H and the mechanisms underlying its enzymatic activity is crucial for the rational design of effective inhibitors within this chemical class.

The primary objective behind the investigation and design of APOBEC3H inhibitors is to gain a comprehensive understanding of the enzyme's functional contributions to innate immunity against retroviruses. These inhibitors serve as indispensable tools in dissecting the complex processes through which APOBEC3H enacts genetic mutations, leading to the suppression of retroviral replication. By selectively inhibiting APOBEC3H, researchers aim to uncover the precise molecular mechanisms underlying its antiretroviral activity. The ongoing refinement and exploration of APOBEC3H inhibitors play a crucial role in advancing our understanding of host-pathogen interactions and the intricate molecular defenses employed by the host organism. By comprehending the intricacies of APOBEC3H inhibition, scientists may unveil new insights into the evolutionary arms race between retroviruses and the host immune system, offering a more nuanced understanding of the fundamental processes that shape genetic diversity in the context of viral encounters.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ribavirin

36791-04-5sc-203238
sc-203238A
sc-203238B
10 mg
100 mg
5 g
$63.00
$110.00
$214.00
1
(1)

An antiviral drug that has been explored for its potential to inhibit APOBEC3H and related APOBEC3 enzymes.

Naproxen

22204-53-1sc-200506
sc-200506A
1 g
5 g
$24.00
$41.00
(1)

A nonsteroidal anti-inflammatory drug (NSAID) that has been reported to inhibit APOBEC3H-mediated hypermutation.

Phenethyl isothiocyanate

2257-09-2sc-205801
sc-205801A
5 g
10 g
$104.00
$183.00
2
(1)

A naturally occurring compound found in cruciferous vegetables, PEITC has been suggested to inhibit APOBEC3H activity

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

A polyphenol found in green tea, EGCG has been suggested to inhibit APOBEC3-mediated hypermutation, including APOBEC3H.

3′-Azido-3′-deoxythymidine

30516-87-1sc-203319
10 mg
$61.00
2
(1)

Zidovudine (AZT) is a well-known nucleoside reverse transcriptase inhibitor. It might also have some impact on APOBEC3H activity.